<?xml-stylesheet type="text/xsl" href="ViewNLM-v2.3.xsl"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id><journal-id journal-id-type="publisher-id">JKMS</journal-id><journal-title-group><journal-title>Journal of Korean Medical Science</journal-title></journal-title-group><issn pub-type="ppub">1011-8934</issn><issn pub-type="epub">1598-6357</issn><publisher><publisher-name>The Korean Academy of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.3346/jkms.2007.22.5.825</article-id><article-id pub-id-type="pmid">17982230</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title><italic>TAP1</italic> and <italic>TAP2</italic> Gene Polymorphisms in Korean Patients with Allergic Rhinitis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Kyung Rae</given-names></name><xref ref-type="aff" rid="A1"/><xref ref-type="author-notes" rid="FN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Cho</surname><given-names>Seok Hyun</given-names></name><xref ref-type="aff" rid="A1"/><xref ref-type="author-notes" rid="FN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Suk Joo</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Jeong</surname><given-names>Jin Hyeok</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Seung Hwan</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Chul Won</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Tae</surname><given-names>Kyung</given-names></name><xref ref-type="aff" rid="A1"/></contrib></contrib-group><aff id="A1">Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Hanyang University, Seoul, Korea.</aff><author-notes><corresp> Address for correspondence: Kyung Tae, M.D. Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Hanyang University, 17 Haengdang-dong, Sungdong-gu, Seoul 133-792, Korea. Tel: +82.2-2290-8585, Fax: +82.2-2293-3335, <email>kytae@hanyang.ac.kr</email></corresp><fn id="FN1" fn-type="equal"><p><sup>*</sup>Equally contributed.</p></fn></author-notes><pub-date pub-type="ppub"><month>10</month><year>2007</year></pub-date><pub-date pub-type="epub"><day>31</day><month>10</month><year>2007</year></pub-date><volume>22</volume><issue>5</issue><fpage>825</fpage><lpage>831</lpage><history><date date-type="received"><day>26</day><month>10</month><year>2006</year></date><date date-type="accepted"><day>13</day><month>2</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 The Korean Academy of Medical Sciences</copyright-statement><copyright-year>2007</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Antigen peptides are actively transported across the endoplasmic reticulum by the transporters associated with antigen presentation (TAP). TAP genes polymorphism could influence the selection process that determines which antigen peptides play a role in the pathogenesis of allergic rhinitis. The aim of this study was to investigate the association of TAP genes polymorphism with allergic rhinitis. <italic>TAP1</italic> and <italic>TAP2</italic> genotyping were performed on 110 allergic rhinitis patients and 107 healthy controls. <italic>TAP1</italic> polymorphic residues at codons 333 and 637, and <italic>TAP2</italic> polymorphic residues at codons 379, 565, 651, and 665 were analyzed by the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR). Analysis of <italic>TAP1</italic> gene polymorphism demonstrated decreased frequencies of Ile/Val genotype at codon 333, Asp/Gly genotype at codon 637, and haplotype A and B in allergic rhinitis patients when compared to controls (<italic>p</italic>&#x0003c;0.05). However, there was no significant difference in the genotype, phenotype, or allele frequencies at four <italic>TAP2</italic> codons between controls and allergic rhinitis patients. In conclusion, <italic>TAP1</italic> gene polymorphism may be an important factor contributing to the genetic susceptibility in the development of allergic rhinitis in the Korean population.</p></abstract><kwd-group><kwd>Allergic Rhinitis</kwd><kwd><italic>TAP1</italic></kwd><kwd><italic>TAP2</italic></kwd><kwd>Polymorphism</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Allergic rhinitis (AR) is an immunologic nasal response, primarily mediated by immunoglobulin E (IgE). It is considered as a heterogenous state, determined by genetic and environmental interactions. Previous studies have shown the relationships between allergies and polymorphisms in many candidate genes such as IgE, transporters associated with antigen processing (TAP), T cell receptors, and cytokines and their receptors (<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B5">5</xref>).</p><p>The inhalent antigens are presented to CD4<sup>+</sup> T cell by MHC class II in AR (<xref ref-type="bibr" rid="B6">6</xref>). However, it was suggested that exogenous antigens can be channeled into the endogenous pathway (MHC class I) by TAP molecules (<xref ref-type="bibr" rid="B7">7</xref>). Therefore, it would be very interesting to determine the other possible antigenic presentation pathway, mediated by TAP in AR.</p><p><italic>TAP1</italic> and <italic>TAP2</italic> genes encode heterodimeric molecules involved in endogenous antigen processing. Antigen peptides are degraded from cytosolic proteins, assembled with MHC class I heavy chain and &#x003b2;2-microglobulin in the endoplasmic reticulum, and actively transported across the endoplasmic reticulum membrane by TAP (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). It is possible that TAP gene polymorphisms can influence the antigen peptide selection and transport process and alter immune response regulation (<xref ref-type="bibr" rid="B2">2</xref>).</p><p>The TAP gene is considered to be one of the candidates for disease susceptibility gene or one of the additional genes conferring susceptibility. Polymorphisms of the TAP gene have been investigated in several HLA-associated diseases such as atopic dermatitis, asthma, rheumatoid arthritis, and systemic lupus erythematosus (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>). There have been few studies on the relationship between AR and TAP genes polymorphism, and it still remained controversial. Ismail et al. (<xref ref-type="bibr" rid="B2">2</xref>) reported evidence of a strong association between <italic>TAP1</italic> polymorphism and atopy in a Tunisian population. However, Tacheuchi et al. (<xref ref-type="bibr" rid="B12">12</xref>) reported no association between <italic>TAP1</italic> gene polymorphism and AR in a Japanese population.</p><p>Until now, there has been no study on the TAP genes polymorphism in Korean patients with AR. Therefore, we designed a case-control study to investigate the <italic>TAP1</italic> and <italic>TAP2</italic> polymorphisms and their association with AR in a Korean population.</p></sec><sec sec-type="methods"><title>MATERIALS AND METHODS</title><sec><title>Subjects</title><p>One hundred and ten consecutive and unrelated patients with AR were included in this study. They consisted of 40 females and 70 males, ranging in age from 5 to 72 yr old (mean, 24.1 yr). All patients had nasal symptoms such as watery rhinorrhea, sneezing, itching and/or nasal obstruction, and positive skin prick tests (Allergopharma&#x000ae;, Hamburg, Germany) for one or more inhalant allergens including house dust mites. There was no co-morbid condition such as allergic asthma or atopic dermatitis. The control group consisted of 107 healthy subjects with no personal or family history of allergic diseases, cancers or genetic diseases. There were 40 females and 67 males ranging from 7-65 yr old (mean, 26.2 yr). All control subjects were negative for all nasal symptoms and skin prick tests. Prior to the experiment, informed consents were obtained from all patients and controls.</p></sec><sec><title>DNA extraction</title><p>Heparinized peripheral venous blood (about 10 mL) was drawn from each individual and stored at -70&#x02103; before being used in the experiment. Genomic DNA was extracted from leukocytes in the collected blood with the Wizard&#x02122; Genomic DNA purification kit (Promega, Madison, WI, U.S.A.).</p></sec><sec><title>ARMS-PCR</title><p>Polymorphic residues at codons 333 and 637 in <italic>TAP1</italic>, and codons 379, 565, 651 and 665 in <italic>TAP2</italic> were analyzed. The dimorphic sites were: <italic>TAP1</italic><sup>333</sup> (A&#x02192;G, Ile&#x02192;Val, exon 4), <italic>TAP1</italic><sup>637</sup> (A&#x02192;G, Asp&#x02192;Gly, exon 10), <italic>TAP2</italic><sup>379</sup> (G&#x02192;A, Val&#x02192;Ile), <italic>TAP2</italic><sup>565</sup> (G&#x02192;A, Ala&#x02192;Thr), <italic>TAP2</italic><sup>651</sup> (C&#x02192;T, Arg&#x02192;Cys) and <italic>TAP2</italic><sup>665</sup> (A&#x02192;G, Thr&#x02192;Ala) (<xref ref-type="bibr" rid="B13">13</xref>). <italic>TAP1</italic> and <italic>TAP2</italic> polymorphism analyses were performed by the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR), described by Newton et al. (<xref ref-type="bibr" rid="B14">14</xref>). Four primers were used for each dimorphic site (<xref ref-type="table" rid="T1">Table 1</xref>). Two of these were complementary to one of the dimorphic sites, while the other two allele-nonspecific primers were used as an internal control. The <italic>TAP1</italic><sup>333</sup>, <italic>TAP1</italic><sup>637</sup>, <italic>TAP2</italic><sup>379</sup>, <italic>TAP2</italic><sup>565</sup> and <italic>TAP2</italic><sup>665</sup> primers were designed as described by Powis et al. (<xref ref-type="bibr" rid="B15">15</xref>). The <italic>TAP2</italic><sup>651</sup> primers were designed as described by Jackson et al. (<xref ref-type="bibr" rid="B16">16</xref>).</p><p>Genomic DNA samples (1 &#x000b5;L) were amplified in a 20 &#x000b5;L reaction mixture containing 1 &#x000b5;L each of all four oligonucleotide primers, 2 &#x000b5;L dNTPs mix (Cat. No. BIO-39029, London, U.K.), 1 &#x000b5;L DNA template, and 13 &#x000b5;L of distilled water. A thermal cycler (GeneAmp PCR system 2400, Perkin Elmer, MA, U.S.A.) was used with the following specifications: 94&#x02103; for 6 min; 35 cycles of 94&#x02103; for 1 min, 62&#x02103; for 1 min and 72&#x02103; for 1 min; there was a final 72&#x02103; incubation for 7 min. The reaction products were separated on a 2% agarose gel stained with ethidium bromide.</p></sec><sec><title>Determination of genotypes and haplotypes</title><p>Genotyping of the <italic>TAP1</italic><sup>333</sup> was done as follows: Ile/Val if 241, 351 and 533 bp bands were visible, Ile/Ile if 241 and 533 bp bands were visible, and Val/Val if 351 and 533 bp bands were visible (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Genotyping of the <italic>TAP1</italic><sup>637</sup> was done as follows: Asp/Gly if 180, 307 and 429 bp bands were visible, Asp/Asp if 307 and 429 bp bands were visible, and Gly/Gly if 180 and 429 bp bands were visible. The <italic>TAP2</italic> genotypes were also classified using the same methods.</p><p>Four possible <italic>TAP1</italic> haplotypes (A-D) were determined by a combination of the dimorphic sites at codons 333 and 637. Eight possible <italic>TAP2</italic> haplotypes (A-H) were determined by combination of four dimorphic sites at codons 379, 565, 651 and 665. We used <italic>TAP1</italic> and <italic>TAP2</italic> haplotype nomenclature as proposed by Powis et al. (<xref ref-type="bibr" rid="B15">15</xref>) and Jackson et al. (<xref ref-type="bibr" rid="B16">16</xref>) (<xref ref-type="table" rid="T2">Table 2</xref>).</p></sec><sec><title>Statistical analysis</title><p>All statistical analyses were performed with SPSS 10.0 (Chicago, IL, U.S.A.). A chi-square test was used to compare the distribution of <italic>TAP1</italic> and <italic>TAP2</italic> genotypes between control and AR groups. Odds ratios (OR) with a 95% confidence interval (CI) were calculated using the Mantel-Haenzel chisquare test. Differences were significant if <italic>p</italic>&#x0003c;0.05.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title><italic>TAP1</italic> polymorphisms and allergic rhinitis</title><p>Three <italic>TAP1</italic> genotypes (Ile/Ile, Ile/Val and Val/Val) were found at codon 333 (<xref ref-type="table" rid="T3">Table 3</xref>). The Ile/Val genotype was significantly decreased in the AR group when compared to Ile/Ile (OR=0.32, 95% CI=0.17-0.60, <italic>p</italic>=0.001). The Val phenotype was significantly decreased in the AR group when compared to the Ile phenotype (OR=0.52, 95% CI=0.30-0.92, <italic>p</italic>=0.016). The Val allele was also significantly decreased in AR patients when compared to the Ile allele (OR=0.48, 95% CI=0.28-0.81, <italic>p</italic>=0.003).</p><p>Three <italic>TAP1</italic> genotypes (Asp/Asp, Asp/Gly and Gly/Gly) were seen at codon 637 (<xref ref-type="table" rid="T3">Table 3</xref>). The Asp/Gly genotype was significantly decreased in the AR group when compared to Asp/Asp (OR=0.43, 95% CI=0.24-0.80, <italic>p</italic>=0.011). In AR patients, the Gly allele was significantly decreased when compared to the Asp (OR=0.62, 95% CI=0.38-1.01, <italic>p</italic>=0.04). However, there was no difference between the two <italic>TAP1</italic><sup>637</sup> phenotypes, Asp and Gly.</p><p>Four possible <italic>TAP1</italic> haplotypes (A-D) were found in this study (<xref ref-type="table" rid="T4">Table 4</xref>). The C and D haplotypes were significantly less than A in the AR group (phenotype, <italic>p</italic>=0.006; allele, <italic>p</italic>=0.0002). By combining the four haplotypes, the following seven genotypes were found: AA, AB, AC, AD, BC, BD, and DD. The AB (OR=0.31), AC (OR=0.08), and AD (OR=0.13) genotypes were significantly decreased in the AR group when compared with the AA genotype.</p></sec><sec><title><italic>TAP2</italic> polymorphisms and allergic rhinitis</title><p>There was no significant difference in the genotype, phenotype, and allele frequencies of <italic>TAP2</italic> at codons 379, 565, 651 and 665 between the AR and control groups (<xref ref-type="table" rid="T5">Table 5</xref>). The previously reported seven <italic>TAP2</italic> haplotypes (A, B, C, D, E, F, and G) were observed; however haplotype H (Ile<sup>379</sup>-Thr<sup>565</sup>-Arg<sup>651</sup>-Ala<sup>665</sup>), reported by Tacheuchi et al. (<xref ref-type="bibr" rid="B17">17</xref>) was not found in this study. A new haplotype (Val<sup>379</sup>-Thr<sup>565</sup>-Arg<sup>651</sup>-Ala<sup>665</sup>) was observed in one person (controls), and we named it as haplotype I (<xref ref-type="table" rid="T2">Table 2</xref>). By combining the eight <italic>TAP2</italic> haplotypes, 18 genotypes could be possible from AA to FG. However, their distributions were not different between the AR and control group (<xref ref-type="table" rid="T6">Table 6</xref>).</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>It is well known that the major histocompatibility complex (MHC) class I and II have fundamentally different antigen processing pathways. The exogenous antigens such as bacteria are degraded into antigenic peptides within the lysosomes. Upon fusion with endosomes, these peptides may bind MHC II molecules (<xref ref-type="bibr" rid="B18">18</xref>). Finally, peptide-loaded MHC class II molecules are delivered to the cell surface, and presented to CD4<sup>+</sup> helper T cells. However, the endogenous antigens such as virus and tumor antigens are degraded within the proteasomes and actively transported across the endoplasmic reticulum membrane by TAP (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). These peptides are then assembled with the MHC class I heavy chain and &#x003b2;2-microglobulin. This complex is expressed on the cell surface, where it is recognized by CD8<sup>+</sup> T cells. Suto et al. (<xref ref-type="bibr" rid="B7">7</xref>) suggested, however, that exogenous antigens can be channeled into the endogenous pathway where antigen presentation is mediated by MHC class I molecules. Therefore, TAP might participate in both endogenous and exogenous antigen processing.</p><p>Because AR is a disease caused by inhalant exogenous antigens such as pollens and house dust mites, the preferential pathway of antigen processing is known to be MHC class II. However, it would be possible that inhalant antigenic peptides can be routed into the MHC class I (endogenous) pathway, involving TAP molecules in AR (<xref ref-type="bibr" rid="B2">2</xref>). The genes encoding the two TAP subunits (<italic>TAP1</italic> and <italic>TAP2</italic>) are located within the MHC class II region between the DPB1 and DQB1 loci (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). Two <italic>TAP1</italic> dimorphic sites (Ile/Val-333 and Asp/Gly-637) and five <italic>TAP2</italic> dimorphic sites (Val/Ile-379, Ala/Thr-565, Arg/Cys-651, Thr/Ala-665 and Stop/Gln-687) have been widely investigated. It is possible that these genetic variations may modify the TAP molecular structures, influencing antigen peptide selection.</p><p>TAP gene polymorphisms have been investigated in several MHC-associated diseases (multiple sclerosis, Grave's disease, and insulin-dependent diabetes mellitus), mostly in Caucasian patients (<xref ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B21">21</xref>). Until now, there have been few studies on AR in an Asian population. Ismail et al. (<xref ref-type="bibr" rid="B2">2</xref>) provided evidence of a strong association between <italic>TAP1</italic> polymorphism and atopy in a Tunisian population. Tacheuchi et al. (<xref ref-type="bibr" rid="B12">12</xref>) reported no association between <italic>TAP1</italic> gene polymorphism and AR in a Japanese population. Therefore, we believe that it is one of the controversial issues in the pathogenetic mechanism of the AR. In this study, we demonstrated a strong association between AR and <italic>TAP1</italic> polymorphism, but not <italic>TAP2</italic>. In the AR group, Ile/Val at <italic>TAP1</italic><sup>333</sup>, Asp/Gly at <italic>TAP1</italic><sup>637</sup>, and <italic>TAP1</italic> haplotypes C and D were significantly decreased when compared to controls. These results are different from those of previous studies. To find any causes of such discrepancy, we compared the results of controls in different ethnics. In our study, a decreased <italic>TAP1</italic> haplotype A frequency and increased haplotype C and D frequencies were observed when compared to the Tunisian (<xref ref-type="bibr" rid="B2">2</xref>) and Japanese (<xref ref-type="bibr" rid="B12">12</xref>) controls. <italic>TAP1</italic> haplotype D also deserves to be mentioned. In control groups, <italic>TAP1</italic> haplotype D was found in 5% of Tunisians (<xref ref-type="bibr" rid="B2">2</xref>), 7.3% of Japanese (<xref ref-type="bibr" rid="B12">12</xref>). However, in our study, <italic>TAP1</italic> haplotype D was found in 11.7% of controls. There might be the various spectrums of genetic pools among different ethnic groups, and therefore, it may be not meaningful to simply compare the results of genetic polymorphisms that have been done in different ethnic groups. Other possible reasons for such discrepancies might be due to multiple factors such as different phenotypic characteristics, heterogeneity within groups of patients and controls, and different genotyping methods.</p><p>In this study, we also analyzed the relationships between <italic>TAP1</italic> gene polymorphisms and the results of allergy tests such as total serum IgE, and the strength and the multiplicity of positive allergens in skin prick tests; however, there was no association between them (data not shown).</p><p>In conclusion, this study showed a meaningful association between AR and a <italic>TAP1</italic> polymorphism, but not <italic>TAP2</italic>. Therefore, it is suggested that a <italic>TAP1</italic> gene polymorphism may be an important factor in AR pathogenesis in a Korean population.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p>This work was supported by the research fund of <funding-source>Hanyang University</funding-source> (Grant No. <award-id>HY-2002-I</award-id>).</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>HE</given-names></name><name><surname>Moffatt</surname><given-names>MF</given-names></name><name><surname>Faux</surname><given-names>JA</given-names></name><name><surname>Walley</surname><given-names>AJ</given-names></name><name><surname>Coleman</surname><given-names>R</given-names></name><name><surname>Trembath</surname><given-names>RC</given-names></name><name><surname>Cookson</surname><given-names>WO</given-names></name><name><surname>Harper</surname><given-names>JI</given-names></name></person-group><article-title>Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor</article-title><source>Br J Dermatol</source><year>1998</year><volume>138</volume><fpage>182</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">9536245</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ismail</surname><given-names>A</given-names></name><name><surname>Bousaffara</surname><given-names>R</given-names></name><name><surname>Kaziz</surname><given-names>J</given-names></name><name><surname>Jili</surname><given-names>J</given-names></name><name><surname>el Kamel</surname><given-names>A</given-names></name><name><surname>Tahar Sfar</surname><given-names>M</given-names></name><name><surname>Remadi</surname><given-names>S</given-names></name><name><surname>Chouchane</surname><given-names>L</given-names></name></person-group><article-title>Polymorphism in transporter antigen peptides gene (TAP1) associated with atopy in Tunisians</article-title><source>J Allergy Clin Immunol</source><year>1997</year><volume>99</volume><fpage>216</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">9042048</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moffatt</surname><given-names>MF</given-names></name><name><surname>Traherne</surname><given-names>JA</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Cookson</surname><given-names>WO</given-names></name></person-group><article-title>Single nucleotide polymorphism and linkage disequilibrium within the TCR alpha/delta locus</article-title><source>Hum Mol Genet</source><year>2000</year><volume>9</volume><fpage>1011</fpage><lpage>1019</lpage><pub-id pub-id-type="pmid">10767325</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JJ</given-names></name><name><surname>Kim</surname><given-names>MS</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Choi</surname><given-names>TW</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Chung</surname><given-names>HT</given-names></name></person-group><article-title>STAT6 gene polymorphisms in allergic rhinitis</article-title><source>Genomics Inform</source><year>2004</year><volume>2</volume><fpage>126</fpage><lpage>130</lpage></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chae</surname><given-names>SC</given-names></name><name><surname>Park</surname><given-names>YR</given-names></name><name><surname>Li</surname><given-names>CS</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Yang</surname><given-names>YS</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><name><surname>Chung</surname><given-names>HT</given-names></name></person-group><article-title>Analysis of the variations in IL-28RA gene and their association with allergic rhinitis</article-title><source>Exp Mol Med</source><year>2006</year><volume>38</volume><fpage>302</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">16819289</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Middleton</surname><given-names>E</given-names><suffix>Jr</suffix></name></person-group><person-group person-group-type="editor"><name><surname>Adkinson</surname><given-names>NF</given-names><suffix>Jr</suffix></name><name><surname>Yunginger</surname><given-names>JW</given-names></name><name><surname>Busse</surname><given-names>WW</given-names></name><name><surname>Bochner</surname><given-names>BS</given-names></name><name><surname>Holgate</surname><given-names>ST</given-names></name><name><surname>Simons</surname><given-names>FE</given-names></name></person-group><article-title>Antigen presentation</article-title><source>Middleton's allergy-principle and practice</source><year>2003</year><volume>Vol 1</volume><edition>6th edition</edition><publisher-loc>PA</publisher-loc><publisher-name>Mosby</publisher-name><fpage>177</fpage><lpage>188</lpage></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suto</surname><given-names>R</given-names></name><name><surname>Srivastava</surname><given-names>PK</given-names></name></person-group><article-title>A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides</article-title><source>Science</source><year>1995</year><volume>269</volume><fpage>1585</fpage><lpage>1588</lpage><pub-id pub-id-type="pmid">7545313</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deverson</surname><given-names>EV</given-names></name><name><surname>Gow</surname><given-names>IR</given-names></name><name><surname>Coadwell</surname><given-names>WJ</given-names></name><name><surname>Monaco</surname><given-names>JJ</given-names></name><name><surname>Butcher</surname><given-names>GW</given-names></name><name><surname>Howard</surname><given-names>JC</given-names></name></person-group><article-title>MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters</article-title><source>Nature</source><year>1990</year><volume>348</volume><fpage>738</fpage><lpage>741</lpage><pub-id pub-id-type="pmid">1979660</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trowsdale</surname><given-names>J</given-names></name><name><surname>Hanson</surname><given-names>I</given-names></name><name><surname>Mockridge</surname><given-names>I</given-names></name><name><surname>Beck</surname><given-names>S</given-names></name><name><surname>Townsend</surname><given-names>A</given-names></name><name><surname>Kelly</surname><given-names>A</given-names></name></person-group><article-title>Sequences encoded in the class II region of the MHC related to the "ABC" superfamily of transporters</article-title><source>Nature</source><year>1990</year><volume>348</volume><fpage>741</fpage><lpage>744</lpage><pub-id pub-id-type="pmid">2259383</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>MC</given-names></name><name><surname>Huang</surname><given-names>CM</given-names></name><name><surname>Wu</surname><given-names>MC</given-names></name><name><surname>Wu</surname><given-names>JY</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name></person-group><article-title>Association of TAP2 gene polymorphisms in Chinese patients with rheumatoid arthritis</article-title><source>Clin Rheumatol</source><year>2004</year><volume>23</volume><fpage>35</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">14749980</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correa</surname><given-names>RA</given-names></name><name><surname>Molina</surname><given-names>JF</given-names></name><name><surname>Pinto</surname><given-names>LF</given-names></name><name><surname>Arcos-Burgos</surname><given-names>M</given-names></name><name><surname>Herrera</surname><given-names>M</given-names></name><name><surname>Anaya</surname><given-names>JM</given-names></name></person-group><article-title>TAP1 and TAP2 polymorphisms analysis in northwestern Colombian patients with systemic lupus erythematosus</article-title><source>Ann Rheum Dis</source><year>2003</year><volume>62</volume><fpage>363</fpage><lpage>365</lpage><pub-id pub-id-type="pmid">12634240</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>K</given-names></name><name><surname>Abe</surname><given-names>S</given-names></name><name><surname>Masuda</surname><given-names>S</given-names></name><name><surname>Yuta</surname><given-names>A</given-names></name><name><surname>Majima</surname><given-names>Y</given-names></name><name><surname>Sakakura</surname><given-names>Y</given-names></name></person-group><article-title>Lack of association between gene polymorphism of transporters associated with antigen processing and allergic rhinitis in a Japanese population</article-title><source>Ann Otol Rhinol Laryngol</source><year>2002</year><volume>111</volume><fpage>460</fpage><lpage>463</lpage><pub-id pub-id-type="pmid">12018331</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>SL</given-names></name><name><surname>Chabod</surname><given-names>J</given-names></name><name><surname>Penfornis</surname><given-names>A</given-names></name><name><surname>Reviron</surname><given-names>D</given-names></name><name><surname>Tiberghien</surname><given-names>P</given-names></name><name><surname>Wendling</surname><given-names>D</given-names></name><name><surname>Toussirot</surname><given-names>E</given-names></name></person-group><article-title>TAP1 and TAP2 gene polymorphism in rheumatoid arthritis in a population in eastern France</article-title><source>Eur J Immunogenet</source><year>2002</year><volume>29</volume><fpage>241</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">12047361</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newton</surname><given-names>CR</given-names></name><name><surname>Graham</surname><given-names>A</given-names></name><name><surname>Heptinstall</surname><given-names>LE</given-names></name><name><surname>Powell</surname><given-names>SJ</given-names></name><name><surname>Summers</surname><given-names>C</given-names></name><name><surname>Kalsheker</surname><given-names>N</given-names></name><name><surname>Smith</surname><given-names>JC</given-names></name><name><surname>Markham</surname><given-names>AF</given-names></name></person-group><article-title>Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)</article-title><source>Nucleic Acids Res</source><year>1989</year><volume>11</volume><fpage>2503</fpage><lpage>2516</lpage><pub-id pub-id-type="pmid">2785681</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powis</surname><given-names>SH</given-names></name><name><surname>Tonks</surname><given-names>S</given-names></name><name><surname>Mockridge</surname><given-names>I</given-names></name><name><surname>Kelly</surname><given-names>AP</given-names></name><name><surname>Bodmer</surname><given-names>JG</given-names></name><name><surname>Trowsdale</surname><given-names>J</given-names></name></person-group><article-title>Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2</article-title><source>Immunogenetics</source><year>1993</year><volume>37</volume><fpage>373</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">8428770</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>DG</given-names></name><name><surname>Capra</surname><given-names>JD</given-names></name></person-group><article-title>TAP2 association with insulin-dependent diabetes mellitus is secondary to HLA-DQB1</article-title><source>Hum immunol</source><year>1995</year><volume>43</volume><fpage>57</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">7558930</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>F</given-names></name><name><surname>Kuwata</surname><given-names>S</given-names></name><name><surname>Nakano</surname><given-names>K</given-names></name><name><surname>Nabeta</surname><given-names>H</given-names></name><name><surname>Hong</surname><given-names>GH</given-names></name><name><surname>Shibata</surname><given-names>Y</given-names></name><name><surname>Tanimoto</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name></person-group><article-title>Association of TAP1 and TAP2 with systemic sclerosis in Japanese</article-title><source>Clin Exp Rheumatol</source><year>1996</year><volume>14</volume><fpage>513</fpage><lpage>521</lpage><pub-id pub-id-type="pmid">8913653</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cresswell</surname><given-names>P</given-names></name></person-group><article-title>Invariant chain structure and MHC class II function</article-title><source>Cell</source><year>1996</year><volume>23</volume><fpage>505</fpage><lpage>507</lpage><pub-id pub-id-type="pmid">8598037</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kellar-Wood</surname><given-names>HF</given-names></name><name><surname>Powis</surname><given-names>SH</given-names></name><name><surname>Gray</surname><given-names>J</given-names></name><name><surname>Compston</surname><given-names>DA</given-names></name></person-group><article-title>MHC-encoded TAP1 and TAP2 dimorphisms in multiple sclerosis</article-title><source>Tissue Antigens</source><year>1994</year><volume>43</volume><fpage>129</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">8016841</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rau</surname><given-names>H</given-names></name><name><surname>Nicolay</surname><given-names>A</given-names></name><name><surname>Usadel</surname><given-names>KH</given-names></name><name><surname>Finke</surname><given-names>R</given-names></name><name><surname>Donner</surname><given-names>H</given-names></name><name><surname>Walfish</surname><given-names>PG</given-names></name><name><surname>Badenhoop</surname><given-names>K</given-names></name></person-group><article-title>Polymorphisms of TAP1 and TAP2 genes in Grave's disease</article-title><source>Tissue Antigens</source><year>1997</year><volume>49</volume><fpage>16</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">9027960</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Endert</surname><given-names>PM</given-names></name><name><surname>Liblau</surname><given-names>RS</given-names></name><name><surname>Patel</surname><given-names>SD</given-names></name><name><surname>Fugger</surname><given-names>L</given-names></name><name><surname>Lopez</surname><given-names>T</given-names></name><name><surname>Pociot</surname><given-names>F</given-names></name><name><surname>Nerup</surname><given-names>J</given-names></name><name><surname>McDevitt</surname><given-names>HO</given-names></name></person-group><article-title>Major histocompatibility complex-encoded antigen processing gene polymorphism in IDDM</article-title><source>Diabetes</source><year>1994</year><volume>43</volume><fpage>110</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">7903260</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. 1</label><caption><p><italic>TAP1</italic> codon 333 genotyping by ARMS-PCR. Four oligonucleotides were included in each polymerase chain reaction mix. Lanes 4, 6, 7, 8 and 11 consist of one control and one allele-specific 241 bp fragment defining the Ile/Ile homozygote. Lanes 1, 2, 3, 9 and 10 consist of one control and two allele-specific, smaller fragments (241 bp and 351 bp) defining the Ile/Val heterozygote. Lane 5 consists of one control and one allele-specific 351 bp fragment defining the Val/Val homozygote.</p></caption><graphic xlink:href="jkms-22-825-g001"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Oligonucleotide primers used for ARMS-PCR <italic>TAP1</italic> and <italic>TAP2</italic> typing</p></caption><graphic xlink:href="jkms-22-825-i001"/><table-wrap-foot><fn><p>ARMS-PCR, amplification refractory mutation system-polymerase chain reaction.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Nomenclature of <italic>TAP1</italic> and <italic>TAP2</italic> haplotypes</p></caption><graphic xlink:href="jkms-22-825-i002"/></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p><italic>TAP1</italic> polymorphisms in allergic rhinitis patients and controls</p></caption><graphic xlink:href="jkms-22-825-i003"/><table-wrap-foot><fn><p><sup>*</sup>, 95% confidence interval.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p><italic>TAP1</italic> haplotypes in allergic rhinitis patients and controls</p></caption><graphic xlink:href="jkms-22-825-i004"/><table-wrap-foot><fn><p><sup>*</sup>, 95% confidence interval.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T5" position="float"><label>Table 5</label><caption><p><italic>TAP2</italic> polymorphisms in allergic rhinitis patients and controls</p></caption><graphic xlink:href="jkms-22-825-i005"/><table-wrap-foot><fn><p><sup>*</sup>, 95% confidence interval.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T6" position="float"><label>Table 6</label><caption><p><italic>TAP2</italic> haplotypes in allergic rhinitis patients and controls</p></caption><graphic xlink:href="jkms-22-825-i006"/><table-wrap-foot><fn><p><sup>*</sup>, 95% confidence interval.</p></fn></table-wrap-foot></table-wrap></floats-group></article>